Mesalamine Delayed-Release Capsules are an
aminosalicylate indicated for the treatment of mildly to moderately active ulcerative colitis in patients five years of age and older, and for the maintenance of remission of ulcerative colitis in adults.
Concomitant
aminosalicylate (n: 24) or biologic agent application (n: 4) was not related to AZA discontinuation (p=0.5).
There are many options namely immunosuppressant medications (glucocorticoids and cyclosporine),
aminosalicylate and, more recently, tumour necrosis factor blocker drugs.1 In general, the treatment of pyoderma gangrenosum is very challenging and difficult.
The following covariates were considered: gender, age, disease duration, disease extension, smoking habit, indication for thiopurine therapy, and concomitant
aminosalicylate treatment.
Mesalamine is an
aminosalicylate anti-inflammatory drug commonly prescribed in patients with IBD.
Hocevar, "Voltammetric measurements of
aminosalicylate drugs using bismuth film electrode," Electrochimica Acta, vol.
Aminosalicylate compounds are frequently prescribed drugs for the control of IBD symptoms in humans.
If the inflammation is confined to the rectum or lower part of the colon, your doctor may prescribe
aminosalicylate drugs for you to self-administer in the form of an enema or suppositories.
AbbVie Inc (NYSE:ABBV), a research-based biopharmaceutical company, announced on Tuesday the approval by Health Canada of HUMIRA (adalimumab) for reducing signs and symptoms and inducing and maintaining clinical remission in paediatric patients 13 to 17 years of age weighing 40 kilograms or more with severely active Crohn's disease and/or who have had an inadequate response or were intolerant to conventional therapy (a corticosteroid and/or
aminosalicylate and/or an immunosuppressant) and/or a tumour necrosis factor alpha antagonist.
2011), including antituberculosis drugs (e.g., isoniazid, rifampicin, sodium
aminosalicylate), anticancer drugs (e.g., amethopterin, mercaptopurine, asparaginase), antithyroid drugs (e.g., carbi-mazole, thiamazolc, thiouracil), antibiotics (e.g., Chloromycetin, erythromycin, myde-camycin), and antipyretic analgesics (Farrell 1997).
The
aminosalicylate group of drugs has become the first-line therapy to induce and maintain remission for mild to moderate inflammatory bowel disease (mild to moderate UC and mild CD) (4-5).